gvtcx

Multi-Drug Resistant TB (MDR-TB) Clinical Advice Service

NHS England Published 12 Jan 2024 Contracts Finder

key details

Value£88,000
Statuscomplete
Category (CPV) 85100000
Deadline17 Mar 2023
Contract start1 Apr 2023
Contract end31 Mar 2025
Proceduredirect
SME suitableYes
OCIDocds-b5fd17-a4893ca3-441c-4648-9d64-e13cc5def33a

Award

SupplierValueDateStatus
British Thoracic Society £88,000 27 Jun 2023 active

description

The MDR-TB Clinical Advice Service provides expert, consistent and safe advice to clinicians treating MDR-TB. The Clinical Advice Service examines and ratifies local MDR-TB centre requests for the use of the MDR-TB agents, Bedaquiline and Delamanid.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
12 Jan 2024 Award (award) · bf598858-3fe7-42df-ae95-d70227d6b5b5-713615

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.